Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-19-000275
Filing Date
2019-11-05
Accepted
2019-11-05 14:03:09
Documents
65
Period of Report
2019-09-28

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20190928x10q.htm   iXBRL 10-Q 3009197
2 EX-31.1 usna-20190928xex31_1.htm EX-31.1 14927
3 EX-31.2 usna-20190928xex31_2.htm EX-31.2 15201
4 EX-32.1 usna-20190928xex32_1.htm EX-32.1 6279
5 EX-32.2 usna-20190928xex32_2.htm EX-32.2 6195
  Complete submission text file 0001562762-19-000275.txt   8656177

Data Files

Seq Description Document Type Size
6 EX-101.SCH usna-20190928.xsd EX-101.SCH 33985
7 EX-101.CAL usna-20190928_cal.xml EX-101.CAL 63365
8 EX-101.DEF usna-20190928_def.xml EX-101.DEF 64734
9 EX-101.LAB usna-20190928_lab.xml EX-101.LAB 271408
10 EX-101.PRE usna-20190928_pre.xml EX-101.PRE 224958
66 EXTRACTED XBRL INSTANCE DOCUMENT usna-20190928x10q_htm.xml XML 1881247
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 191192718
SIC: 2833 Medicinal Chemicals & Botanical Products